Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
Express Scripts
QuintilesIMS
McKesson
Fish and Richardson
Cipla
Medtronic
Julphar
Mallinckrodt

Generated: January 21, 2018

DrugPatentWatch Database Preview

LEVO-T Drug Profile

« Back to Dashboard

Which patents cover Levo-t, and when can generic versions of Levo-t launch?

Levo-t is a drug marketed by Alara Pharm and is included in one NDA. There is one patent protecting this drug.

This drug has eight patent family members in seven countries.

The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Summary for LEVO-T
Drug patent expirations by year for LEVO-T
Pharmacology for LEVO-T
Ingredient-typeThyroxine
Drug Classl-Thyroxine

US Patents and Regulatory Information for LEVO-T

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-004 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-011 Mar 1, 2002 AB1,AB2,AB3 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-012 Dec 8, 2003 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-002 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-003 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-006 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-005 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alara Pharm LEVO-T levothyroxine sodium TABLET;ORAL 021342-009 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for LEVO-T

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Accenture
Cerilliant
Fish and Richardson
Express Scripts
Citi
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot